CSIMarket
Company Name or Ticker Symbol
Search for other Categories
 


<
Catabasis Pharmaceuticals Inc  (CATB)
Other Ticker:  
 
    Sector  Healthcare    Industry Major Pharmaceutical Preparations
 


 

Catabasis Pharmaceuticals Inc

CATB's Financial Statements and Analysis




Catabasis Pharmaceuticals Inc narrowed I. Quarter net loss per share of $-0.41 compare to net loss per share of $-0.61 recorded in the same quarter a year ago and improved compare to net loss per share of $-0.47 realized in previous quarter.

Catabasis Pharmaceuticals Inc's Revenue fell by % in I. Quarter (Mar 31 2017) year on year, to $0 million and declined by sequentially.


Catabasis Pharmaceuticals Inc is
More on CATB's Income Statement

I. Quarter
Earnings Per Share Revenues
$ -0.41 $  0 Mill
$+0.20     Unch.    
You need to upgrade your Flash Player
CATB's NET INCOME

Catabasis Pharmaceuticals Inc's in I. Quarter recorded net loss of $-8 million, an improvement compare to net loss of $-9 million in I. Quarter a year ago.

Sequentially net loss narrowed from net loss of $-8.78 million realized in previous quarter.

More on CATB's Growth

CATB's Cash flow In I. Quarter company's net cash flow was $8 million, capital expenditures grew by -96.90%, to $-0 millions compare to same quarter a year ago and rose by -60.87% from IV. Quarter (Dec 31 2016).

More on CATB's Cash flow Statement



Catabasis Pharmaceuticals Inc does not pay out common stock dividend.

In trailing twelve-month period Catabasis Pharmaceuticals Inc payed $ -1.67 cash per share, on a free-cash flow basis .

Book value fell by -19.34 % sequentially to $1.25 per share, -14.82% of net loss per share in trailing twelve-month period were subtructed from shareholder value.
Tangible Book value fell to $ 1.25 per share from $ 1.56.

Company issued 0.39 million shares or 2.11 % in I. Quarter.


More on CATB's Dividends
 Market Capitalization (Millions) 26
 Shares Outstanding (Millions) 19
 Total Debt (Millions $) 3
 Revenue (TTM) (Millions $) -
 Net Income (TTM) (Millions $) -35
 Cash Flow (TTM) (Millions $) 8
 Capital Exp. (TTM) (Millions $) -0
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Employees (TTM) $ -


   



CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2017 CSIMarket, Inc. All rights reserved. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)
Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com